Dongyang Guangyao submitted a prospectus to be listed in Hong Kong by way of introduction. On December 11th, Dongyangguang Pharmaceutical, the controlling shareholder of Dongyangguang Changjiang Pharmaceutical, submitted a prospectus to the Hong Kong Stock Exchange to be listed in Hong Kong by way of introduction, and the exclusive sponsor was CICC.The United States ITC issued a 337-part final ruling on the wireless front-end module and its downstream equipment. According to the China Trade Relief Information Network, on December 10, 2024, the United States International Trade Commission (ITC) issued a notice saying that it made a 337-part final ruling on a specific wireless front-end module and its downstream equipment: the preliminary ruling (No.13) made by the administrative judge in this case on November 8, 2024 will not be reviewed, that is, based on the withdrawal of the applicant, Kangxi Communication Technology (Shanghai) Co., Ltd. and Ruijie Network Co., Ltd. are listed as defendants.Blinken arrived in Jordan to attend an emergency meeting on Syria. It is reported that US Secretary of State Blinken arrived in Jordan on Thursday to attend an emergency meeting on Syria. Blinken will meet with Jordanian Foreign Minister Assafadi and King Abdullah.
Vassilis, a foreign exchange strategist, quickly commented on the ECB's resolution: the euro fell to a new low because the ECB gave up the "restrictive policy" part of the statement, but this does not mean that the policy language is downright dovish. Bonds in the euro zone are in a moderate trend.The Baltic dry bulk freight index fell 4.61% to 1055 points.ECB: Financing conditions are relaxing, ECB: Financing conditions are relaxing. However, because monetary policy is still restrictive and past interest rate hikes are still being transmitted to the credit stock, financing conditions are still tightening. Inflation prospect, core inflation and its transmission will determine the interest rate path.
Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).Guan Qingyou: I am optimistic about the stock market by cutting interest rates and lowering the RRR. For example, Guan Qingyou, president and chief economist of the Financial Research Institute, said that lowering the RRR and raising interest rates will definitely happen, and from the downward trend of previous interest rates, it should be faster. Regarding the current market conditions, Guan Qingyou said that different subjects have different judgments on the market trend in one or two trading days, but he is still optimistic, and said that the positive impact of the current policy change on the capital market cannot be underestimated. Combining industrial structure and policy orientation, Guan Qingyou said that consumer companies, technology companies, and mergers and acquisitions involving the transformation and upgrading of traditional industries to emerging formats are all his optimistic directions. In addition, for the economic growth target in 2025, Guan Qingyou believes that "the target of 5% can still be contested". He also said that 2025 will be better than 2024. "In 2025, the adjustment of policies will bring more increments to the market and industry." (sohu finance)Zhongding Co., Ltd. established a subsidiary of Robotics Technology. Tianyancha APP shows that Anhui Ruisibo Robotics Technology Co., Ltd. was recently established, with Xia Yingsong as its legal representative and a registered capital of 50 million yuan. Its business scope includes: research and development of intelligent robots; Intelligent robot sales; Industrial robot manufacturing; Industrial robot sales and so on. Tianyancha's equity penetration shows that the company is wholly owned by Zhongding.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide